Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane vs Taxol in Advanced NSCLC
NCT00540514Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Nov 2007
- Primary completion
- Oct 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of nab-paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Celgene Corporation. Started Nov 2007; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00540514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540514.